![Stephen Bardin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 35 131 $ am 31.05.2026
Stephen Bardin is currently Chief Financial & Accounting Officer at CalciMedica, Inc. since 2024.
Formerly, Mr. Bardin was Chief Financial Officer at Atai Beckley NV from 2022 to 2023.
From 2019 to 2022, Mr. Bardin was Senior Vice President-Finance & Operations at BridgeBio Pharma, Inc. and also held the position of Senior Vice President-Operations & Finance at BridgeBio Pharma, Inc. Education includes an undergraduate degree from Duke University and an MBA from Stanford Graduate School of Business.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CALCIMEDICA, INC. 0,27 % | 26.06.2025 | 43 000 ( 0,27 % ) | 35 131 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CALCIMEDICA, INC. | Finanzdirektor/CFO | 01.11.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
ATAI Life Sciences NV
 ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Finanzdirektor/CFO | 13.10.2023 |
| BRIDGEBIO PHARMA, INC. | Corporate Officer/Principal | 01.06.2022 |
| BRIDGEBIO PHARMA, INC. | Finanzdirektor/CFO | 01.06.2022 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 5 |
|---|---|
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BridgeBio Pharma, Inc.
 BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients | Health Technology |
ATAI Life Sciences NV
ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
CalciMedica, Inc.
 CalciMedica, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
